SPONSOR
National Cancer Institute, Egypt
Total Trials
4
Recruiting
4
Phases
N/A
Conditions studied: Breast CancerRenal NeoplasmInguinal Lymph Nodes EnlargedIntrathecalDexmedetomidineFentanylBupivacaineSpinal AnesthesiaAbove Knee AmputationSarcomas
National Cancer Institute, Egypt is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Breast Cancer, Renal Neoplasm, Inguinal Lymph Nodes Enlarged, Intrathecal.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Cancer Institute, Egypt
How many clinical trials has National Cancer Institute, Egypt sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by National Cancer Institute, Egypt, of which 4 are actively recruiting participants. These trials cover conditions including Breast Cancer, Renal Neoplasm, Inguinal Lymph Nodes Enlarged. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Cancer Institute, Egypt research focus on?
National Cancer Institute, Egypt clinical trials span Breast Cancer, Renal Neoplasm, Inguinal Lymph Nodes Enlarged, Intrathecal, Dexmedetomidine, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a National Cancer Institute, Egypt clinical trial?
To participate in a National Cancer Institute, Egypt trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Cancer Institute, Egypt trials with current recruitment status updated daily.
Clinical Trials by National Cancer Institute, Egypt
NCT06888258
Recruiting
Compare Analgesia Between MTP Block And ESPB in MRM
Breast Cancer
NCT06501079
Recruiting
Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy
Renal Neoplasm
NCT07331129
Recruiting
The Analgesic Efficacy of Ultrasound Guided Transversalis Fascia Plane Block in Inguinal Lymph Node Dissection
Inguinal Lymph Nodes Enlarged
NCT07276867
Recruiting
Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity
Intrathecal
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology